Jilin Aodong Pharmaceutical Group Co., Ltd.

SZSE:000623 Voorraadrapport

Marktkapitalisatie: CN¥22.1b

Jilin Aodong Pharmaceutical Group Beheer

Beheer criteriumcontroles 3/4

De CEO Jilin Aodong Pharmaceutical Group is Shuqin Guo, benoemd in Jul2017, heeft een ambtstermijn van 7.33 jaar. bezit rechtstreeks 0.17% van de aandelen van het bedrijf, ter waarde CN¥ 37.43M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.3 jaar en 7.3 jaar.

Belangrijke informatie

Shuqin Guo

Algemeen directeur

CN¥2.6m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO7.3yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn7.3yrs
Gemiddelde ambtstermijn bestuur7.3yrs

Recente managementupdates

Recent updates

We Think That There Are More Issues For Jilin Aodong Pharmaceutical Group (SZSE:000623) Than Just Sluggish Earnings

Nov 06
We Think That There Are More Issues For Jilin Aodong Pharmaceutical Group (SZSE:000623) Than Just Sluggish Earnings

Market Might Still Lack Some Conviction On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) Even After 36% Share Price Boost

Oct 01
Market Might Still Lack Some Conviction On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) Even After 36% Share Price Boost

A Look At The Intrinsic Value Of Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Aug 22
A Look At The Intrinsic Value Of Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Jilin Aodong Pharmaceutical Group (SZSE:000623) Is Increasing Its Dividend To CN¥0.60

Jul 05
Jilin Aodong Pharmaceutical Group (SZSE:000623) Is Increasing Its Dividend To CN¥0.60

Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Jun 03
Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Apr 23
There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

CEO

Shuqin Guo (61 yo)

7.3yrs

Tenure

CN¥2,613,100

Compensatie

Ms. Shuqin Guo serves Vice Chairman and General Manager of Jilin Aodong Pharmaceutical Group Co., Ltd. (formerly known as Jilin Aodong Medicine Industry Group Co., Ltd) since July 17, 2017.


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Shuqin Guo
Vice Chairman & GM7.3yrsCN¥2.61m0.17%
CN¥ 37.4m
Shuyuan Zhang
CFO, Financial Director7.3yrsCN¥785.10k0.013%
CN¥ 2.9m
Kai Yang
Deputy GM & Director7.3yrsCN¥805.10k0.013%
CN¥ 2.9m
Zhen Yu Wang
Deputy GM2.8yrsCN¥735.10k0.0085%
CN¥ 1.9m
Xiaolin Lin
Deputy General Manager2.8yrsCN¥335.10k0.0017%
CN¥ 368.9k

7.3yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 000623 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.3 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Shuqin Guo
Vice Chairman & GM7.3yrsCN¥2.61m0.17%
CN¥ 37.4m
Shuyuan Zhang
CFO, Financial Director7.3yrsCN¥785.10k0.013%
CN¥ 2.9m
Kai Yang
Deputy GM & Director7.3yrsCN¥805.10k0.013%
CN¥ 2.9m
Zhen Yu Wang
Deputy GM7.3yrsCN¥735.10k0.0085%
CN¥ 1.9m
Xiulin Li
Chairman31.8yrsCN¥3.21m0.31%
CN¥ 67.5m
Yongfeng Chen
Chief Supervisor7.3yrsCN¥701.50k0.013%
CN¥ 2.9m
Yuju Sun
Member of Supervisory Board16.5yrsCN¥10.00kgeen gegevens
Dalong Zhao
Director4.3yrsCN¥735.10k0.0061%
CN¥ 1.3m
Gang Xiu
Member of Supervisory Board7.3yrsgeen gegevensgeen gegevens
Biming Liang
Independent Director1.3yrsCN¥60.00kgeen gegevens
Peng Li
Independent Director4.3yrsCN¥132.50kgeen gegevens
Weiwei Xiao
Independent Director4.3yrsCN¥132.50kgeen gegevens

7.3yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 000623 wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.3 jaar).